Lastly, Canning et al. demonstrated that Gal-3 acts as an AGE receptor in the retina and that diabetes in Gal-3 KO mice leads to overall less severe retinal disease, and specifically milder BRB dysfunction and reduced retinal VEGF levels (Canning et al., 2007). This evidence concerns the gene VEGFA and Abnormal retinal morphology.